Tdap vax safe during pregnancy; UNICEF opens Fiji facility; Novavax appoints new SVP;

> Receiving the Tdap vaccine during pregnancy does not increase the risk of adverse events for the mother or the infant, a JAMA study says. Release

> UNICEF has opened a vaccine storage facility in Fiji that will deliver to 13 countries across the region. More

> Novavax ($NVAX) has appointed Sven Andréasson its SVP of corporate development. Release

> Savsu Technologies has scored World Health Organization approval for its new long-range vaccine carrier. Release

> Researchers are pursuing a powdered nasal vaccine against West Nile. More

> Swedish scientists are looking to test a heart attack vaccine in India. More

> A product design student in India has developed a portable vaccine cooler for the last mile of the cold chain. More

And Finally... Maryland-based biotech Sanaria is hoping to crowdfund the production of a robot that can manufacture its malaria vaccine candidate. More

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.